Plotted Points Statistics |
11-KETOTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 91% | 17% | 90% | 18% |
Total | 32 | 91% | 17% | 90% | 18% |
Sample Statistics |
11-KETOTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 86% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 38 | . | |
False Negatives | 5 | 14% | 5 out of 37 |
Not Spiked | 97 | . | |
False Positives | 0 | 0% | 0 out of 96 |
Plotted Points Statistics |
17-ALPHA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 73 | 86% | 13% | 86% | 13% |
Total | 73 | 86% | 13% | 86% | 13% |
Sample Statistics |
17-ALPHA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 73 | 94% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 4% | Spiked |
Spiked | 79 | . | |
False Negatives | 2 | 3% | 2 out of 78 |
Not Spiked | 56 | . | |
False Positives | 0 | 0% | 0 out of 56 |
BQS OBSP Determination: |
17-ALPHA-ETHYNYLESTRADIOL |
METHOD: 4434 , TESTIDCODE: 64529GM005 |
Open Data Set |
Plotted Points Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 68 | 80% | 13% | 79% | 13% |
Total | 68 | 80% | 13% | 79% | 13% |
Sample Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 68 | 85% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 81 | . | |
False Negatives | 12 | 15% | 12 out of 80 |
Not Spiked | 54 | . | |
False Positives | 0 | 0% | 0 out of 54 |
Plotted Points Statistics |
17-BETA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 71 | 88% | 18% | 85% | 15% |
Total | 71 | 88% | 18% | 85% | 15% |
Sample Statistics |
17-BETA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 71 | 91% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 79 | . | |
False Negatives | 6 | 8% | 6 out of 78 |
Not Spiked | 56 | . | |
False Positives | 0 | 0% | 0 out of 56 |
Plotted Points Statistics |
3-BETA-COPROSTANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 59 | 87% | 25% | 89% | 26% |
Total | 59 | 87% | 25% | 89% | 26% |
Sample Statistics |
3-BETA-COPROSTANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 83% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 73 | . | |
False Negatives | 12 | 17% | 12 out of 71 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 51 |
Plotted Points Statistics |
4,4BISPHENOL F |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 11 | 100% | 29% | 88% | 32% |
Total | 11 | 100% | 29% | 88% | 32% |
Sample Statistics |
4,4BISPHENOL F |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 11 | 100% | Spiked |
Estimated Values | 11 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 11 | . | |
False Negatives | 0 | 0% | 0 out of 11 |
Not Spiked | 15 | . | |
False Positives | 0 | 0% | 0 out of 15 |
Sample Statistics |
4,4BISPHENOL S |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 0 | . | Spiked |
Estimated Values | 0 | . | Spiked |
Deleted Values | 2 | 100% | Spiked + Not Spiked |
Spiked, Censored | 0 | . | Spiked |
Spiked | 0 | . | |
False Negatives | 0 | . | 0 out of 0 |
Not Spiked | 2 | . | |
False Positives | 0 | . | 0 out of 0 |
Plotted Points Statistics |
4-ANDROSTENE-3,17-DIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 36 | 70% | 21% | 70% | 20% |
Total | 36 | 70% | 21% | 70% | 20% |
Sample Statistics |
4-ANDROSTENE-3,17-DIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 88% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 42 | . | |
False Negatives | 4 | 10% | 4 out of 41 |
Not Spiked | 93 | . | |
False Positives | 0 | 0% | 0 out of 92 |
Plotted Points Statistics |
BISPHENOL A |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 111% | 8% | 108% | 8% |
>= Reporting Level | 64 | 78% | 21% | 77% | 24% |
Total | 68 | 80% | 22% | 80% | 23% |
Sample Statistics |
BISPHENOL A |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 68 | 94% | Spiked |
Estimated Values | 24 | 33% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 3 | 4% | Spiked |
Spiked | 74 | . | |
False Negatives | 1 | 1% | 1 out of 72 |
Not Spiked | 61 | . | |
False Positives | 0 | 0% | 0 out of 60 |
Plotted Points Statistics |
CHOLESTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 71 | 89% | 20% | 88% | 20% |
Total | 71 | 89% | 20% | 88% | 20% |
Sample Statistics |
CHOLESTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 71 | 99% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 74 | . | |
False Negatives | 1 | 1% | 1 out of 72 |
Not Spiked | 50 | . | |
False Positives | 2 | 4% | 2 out of 50 |
Plotted Points Statistics |
CIS-ANDROSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 80% | 26% | 80% | 16% |
Total | 57 | 80% | 26% | 80% | 16% |
Sample Statistics |
CIS-ANDROSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 89% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 64 | . | |
False Negatives | 6 | 9% | 6 out of 64 |
Not Spiked | 71 | . | |
False Positives | 1 | 1% | 1 out of 69 |
Plotted Points Statistics |
DIHYDROTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 67% | 24% | 66% | 12% |
Total | 39 | 67% | 24% | 66% | 12% |
Sample Statistics |
DIHYDROTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 87% | Spiked |
Estimated Values | 4 | 9% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 6 | 13% | 6 out of 45 |
Not Spiked | 90 | . | |
False Positives | 1 | 1% | 1 out of 89 |
Plotted Points Statistics |
EPITESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 75% | 20% | 73% | 13% |
Total | 61 | 75% | 20% | 73% | 13% |
Sample Statistics |
EPITESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 95% | Spiked |
Estimated Values | 3 | 5% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 66 | . | |
False Negatives | 3 | 5% | 3 out of 64 |
Not Spiked | 69 | . | |
False Positives | 0 | 0% | 0 out of 69 |
Plotted Points Statistics |
EQUILENIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 89% | 37% | 85% | 44% |
Total | 32 | 89% | 37% | 85% | 44% |
Sample Statistics |
EQUILENIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 86% | Spiked |
Estimated Values | 2 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 37 | . | |
False Negatives | 5 | 14% | 5 out of 37 |
Not Spiked | 45 | . | |
False Positives | 3 | 7% | 3 out of 45 |
Plotted Points Statistics |
EQUILIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 71% | 18% | 64% | 1% |
>= Reporting Level | 62 | 68% | 17% | 66% | 18% |
Total | 67 | 68% | 17% | 66% | 17% |
Sample Statistics |
EQUILIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 67 | 88% | Spiked |
Estimated Values | 67 | 88% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 78 | . | |
False Negatives | 8 | 11% | 8 out of 76 |
Not Spiked | 57 | . | |
False Positives | 0 | 0% | 0 out of 57 |
Plotted Points Statistics |
ESTRIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 76% | 11% | 81% | 15% |
>= Reporting Level | 72 | 78% | 16% | 78% | 17% |
Total | 75 | 78% | 15% | 78% | 17% |
Sample Statistics |
ESTRIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 75 | 90% | Spiked |
Estimated Values | 5 | 6% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 84 | . | |
False Negatives | 7 | 8% | 7 out of 83 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 51 |
Plotted Points Statistics |
ESTRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 69 | 82% | 19% | 77% | 19% |
Total | 69 | 82% | 19% | 77% | 19% |
Sample Statistics |
ESTRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 69 | 85% | Spiked |
Estimated Values | 3 | 4% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 4 | 5% | Spiked |
Spiked | 81 | . | |
False Negatives | 8 | 10% | 8 out of 81 |
Not Spiked | 54 | . | |
False Positives | 0 | 0% | 0 out of 51 |
Plotted Points Statistics |
MESTRANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 143% | . | 143% | 0% |
>= Reporting Level | 58 | 59% | 30% | 52% | 16% |
Total | 59 | 60% | 31% | 52% | 17% |
Sample Statistics |
MESTRANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 75% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 79 | . | |
False Negatives | 20 | 25% | 20 out of 79 |
Not Spiked | 56 | . | |
False Positives | 1 | 2% | 1 out of 55 |
Plotted Points Statistics |
NORETHINDRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 105% | . | 105% | 0% |
>= Reporting Level | 63 | 80% | 16% | 77% | 17% |
Total | 64 | 80% | 16% | 77% | 18% |
Sample Statistics |
NORETHINDRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 64 | 82% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 2 | 3% | Spiked |
Spiked | 79 | . | |
False Negatives | 12 | 15% | 12 out of 78 |
Not Spiked | 56 | . | |
False Positives | 0 | 0% | 0 out of 55 |
Plotted Points Statistics |
PROGESTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 71 | 48% | 22% | 44% | 14% |
Total | 71 | 48% | 22% | 44% | 14% |
Sample Statistics |
PROGESTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 71 | 90% | Spiked |
Estimated Values | 71 | 90% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 80 | . | |
False Negatives | 8 | 10% | 8 out of 79 |
Not Spiked | 55 | . | |
False Positives | 0 | 0% | 0 out of 55 |
Plotted Points Statistics |
TESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 50 | 77% | 13% | 77% | 11% |
Total | 50 | 77% | 13% | 77% | 11% |
Sample Statistics |
TESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 50 | 89% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 56 | . | |
False Negatives | 6 | 11% | 6 out of 56 |
Not Spiked | 79 | . | |
False Positives | 0 | 0% | 0 out of 77 |
BQS OBSP Determination: |
TRANS-DIETHYLSTILBESTROL |
METHOD: 4434 , TESTIDCODE: 64536GM005 |
Open Data Set |